Citations (90)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (19)
Ali Shojaie, Silvia Rota, Ahmad Al Khleifat, K Ray Chaudhuri & Ammar Al-Chalabi. (2023) Non-motor symptoms in amyotrophic lateral sclerosis: lessons from Parkinson’s disease. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:7-8, pages 562-571.
Read now
Read now
Marion Sommers-Spijkerman, Melinda S. Kavanaugh, Esther Kruitwagen-Van Reenen, Aimée Zwarts-Engelbert, Johanna M. A. Visser-Meily & Anita Beelen. (2023) Stigma experienced by ALS/PMA patients and their caregivers: a mixed-methods study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 327-338.
Read now
Read now
Paulos Gebrehiwet, Lisa Meng, Stacy A. Rudnicki, Phil Sarocco, Jenny Wei, Andrew A. Wolff, Adriano Chiò, Jinsy A. Andrews, Angela Genge, Carlayne E. Jackson, Noah Lechtzin, Timothy M. Miller & Jeremy M. Shefner. (2023) MiToS and King’s staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 304-310.
Read now
Read now
Thomas Meyer, Susanne Spittel, Torsten Grehl, Ute Weyen, Robert Steinbach, Dagmar Kettemann, Susanne Petri, Patrick Weydt, René Günther, Petra Baum, Elena Schlapakow, Jan Christoph Koch, Matthias Boentert, Joachim Wolf, Julian Grosskreutz, Annekathrin Rödiger, Benjamin Ilse, Moritz Metelmann, Jenny Norden, Ruhan Yasemin Koc, Péter Körtvélyessy, Alessio Riitano, Bertram Walter, Barbara Hildebrandt, Friedrich Schaudinn, Christoph Münch & André Maier. (2023) Remote digital assessment of amyotrophic lateral sclerosis functional rating scale – a multicenter observational study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 175-184.
Read now
Read now
C. A. Young, J. Ealing, C. J. McDermott, T. L. Williams, A. Al-Chalabi, T. Majeed, K. Talbot, T. Harrower, C. Faull, A. Malaspina, J. Annadale, R. J. Mills & A. Tennant. (2023) Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:1-2, pages 82-90.
Read now
Read now
Rubika Balendra, Ashley R. Jones, Ahmad Al Khleifat, Theresa Chiwera, Paul Wicks, Carolyn A. Young, Pamela J. Shaw, Martin R. Turner, P. Nigel Leigh & Ammar Al-Chalabi. (2023) Comparison Of King’s Clinical Staging In Multinational Amyotrophic Lateral Sclerosis Cohorts. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:1-2, pages 71-81.
Read now
Read now
Jaime Luna, Philippe Couratier, Sanae Lahmadi, Géraldine Lautrette, Andrea Fontana, Rosanna Tortelli, Giancarlo Logroscino, Pierre-Marie Preux, Massimilano Copetti & Marin Benoit. (2021) Comparison of the ability of the King’s and MiToS staging systems to predict disease progression and survival in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:7-8, pages 478-485.
Read now
Read now
Nur Adilah Abdul Aziz, Tsun-Haw Toh, Ee-Chin Loh, David Paul Capelle, Khean-Jin Goh, Lydia Abdul Latif, Tze-Yang Chung & Nortina Shahrizaila. (2021) The utility of ALS staging systems in a multi-ethnic patient cohort. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:5-6, pages 341-349.
Read now
Read now
Kazuo Sugimoto, Masahiro Mori, Jia Liu, Kazutomo Shibuya, Sagiri Isose, Mizuho Koide, Takaki Hiwasa & Satoshi Kuwabara. (2021) Novel serum autoantibodies against ß-actin (ACTB) in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:5-6, pages 388-394.
Read now
Read now
Ahmad Al Khleifat, Rubika Balendra, Ton Fang & Ammar Al-Chalabi. (2021) Intuitive Staging Correlates With King’s Clinical Stage. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:5-6, pages 336-340.
Read now
Read now
Ruben P.A. van Eijk, Adriaan D. de Jongh, Stavros Nikolakopoulos, Christopher J. McDermott, Marinus J.C. Eijkemans, Kit C.B. Roes & Leonard H. van den Berg. (2021) An old friend who has overstayed their welcome: the ALSFRS-R total score as primary endpoint for ALS clinical trials. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:3-4, pages 300-307.
Read now
Read now
Monica Consonni, Eleonora Dalla Bella, Enrica Bersano, Alessandra Telesca & Giuseppe Lauria. (2021) Cognitive reserve is associated with altered clinical expression in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:3-4, pages 237-247.
Read now
Read now
Umberto Manera, Sara Cabras, Margherita Daviddi, Rosario Vasta, Maria Claudia Torrieri, Francesca Palumbo, Alessandro Bombaci, Maurizio Grassano, Luca Solero, Laura Peotta, Barbara Iazzolino, Antonio Canosa, Andrea Calvo, Adriano Chiò & Cristina Moglia. (2021) Validation of the Italian version of self-administered ALSFRS-R scale. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:1-2, pages 151-153.
Read now
Read now
Julian Gold, Dominic B. Rowe, Matthew C. Kiernan, Steve Vucic, Susan Mathers, Ruben P. A. van Eijk, Avindra Nath, Marta Garcia Montojo, Gina Norato, Ulisses A. Santamaria, Mary-Louise Rogers, Andrea Malaspina, Vittoria Lombardi, Puja R. Mehta, Henk-Jan Westeneng, Leonard H. van den Berg & Ammar Al-Chalabi. (2019) Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:7-8, pages 595-604.
Read now
Read now
Rubika Balendra, Ahmad Al Khleifat, Ton Fang & Ammar Al-Chalabi. (2019) A standard operating procedure for King’s ALS clinical staging. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 159-164.
Read now
Read now
. (2018) Theme 9 Clinical trials and trial design. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:sup1, pages 264-281.
Read now
Read now
Nimish J. Thakore, Brittany R. Lapin, Tyler G. Kinzy & Erik P. Pioro. (2018) Deconstructing progression of amyotrophic lateral sclerosis in stages: a Markov modeling approach. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 483-494.
Read now
Read now
Nuria Gonzalez Calzada, Enric Prats Soro, Lluis Mateu Gomez, Esther Giro Bulta, Ana Cordoba Izquierdo, Monica Povedano Panades, Jordi Dorca Sargatal & Eva Farrero Muñoz. (2016) Factors predicting survival in amyotrophic lateral sclerosis patients on non-invasive ventilation. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:5-6, pages 337-342.
Read now
Read now
H Blasco, F Patin, CR Andres, P Corcia & PH Gordon. (2016) Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection. Expert Opinion on Pharmacotherapy 17:12, pages 1669-1682.
Read now
Read now
Articles from other publishers (71)
Ting Shen, Jacob W. Vogel, Jeffrey Duda, Jeffrey S. Phillips, Philip A. Cook, James Gee, Lauren Elman, Colin Quinn, Defne A. Amado, Michael Baer, Lauren Massimo, Murray Grossman, David J. Irwin & Corey T. McMillan. (2023) Novel data-driven subtypes and stages of brain atrophy in the ALS–FTD spectrum. Translational Neurodegeneration 12:1.
Crossref
Crossref
Marlene Tahedl, Ee Ling Tan, Rangariroyashe H. Chipika, Jasmin Lope, Jennifer C. Hengeveld, Mark A. Doherty, Russell L. McLaughlin, Orla Hardiman, Siobhan Hutchinson, Mary Clare McKenna & Peter Bede. (2023) The involvement of language‐associated networks, tracts, and cortical regions in frontotemporal dementia and amyotrophic lateral sclerosis: Structural and functional alterations. Brain and Behavior 13:11.
Crossref
Crossref
Katie Stenson, Lasair O'Callaghan, Jennifer Mellor, Jack Wright, Gregor Gibson, Lucy Earl, Sophie Barlow & Christina Nicole Fournier. (2023) Healthcare resource utilization at different stages of amyotrophic lateral sclerosis: Results from a real-world survey. Journal of the Neurological Sciences 452, pages 120764.
Crossref
Crossref
Felix Heinrich, Isabell Cordts, René Günther, Benjamin Stolte, Daniel Zeller, Carsten Schröter, Ute Weyen, Martin Regensburger, Joachim Wolf, Ilka Schneider, Andreas Hermann, Moritz Metelmann, Zacharias Kohl, Ralf A. Linker, Jan Christoph Koch, Florentine Radelfahr, Erik Schönfelder, Pavel Gardt, Tara Mohajer-Peseschkian, Alma Osmanovic, Thomas Klopstock, Johannes Dorst, Albert C. Ludolph, Oliver Schöffski, Matthias Boentert, Tim Hagenacker, Marcus Deschauer, Paul Lingor, Susanne Petri & Olivia Schreiber-Katz. (2023) Economic evaluation of Motor Neuron Diseases: a nationwide cross-sectional analysis in Germany. Journal of Neurology.
Crossref
Crossref
Pramod Kumar Pisharady, Lynn E. Eberly, Isaac M. Adanyeguh, Georgios Manousakis, Gaurav Guliani, David Walk & Christophe Lenglet. (2023) Multimodal MRI improves diagnostic accuracy and sensitivity to longitudinal change in amyotrophic lateral sclerosis. Communications Medicine 3:1.
Crossref
Crossref
Reza Boostani, Nahid Olfati, Hosein Shamshiri, Zanireh Salimi, Farzad Fatehi, Seyed Arya Hedjazi, Atefeh Fakharian, Majid Ghasemi, Ali Asghar Okhovat, Keivan Basiri, Bahram Haghi Ashtiani, Behnaz Ansari, Gholam Reza Raissi, Seyed Ahmadreza Khatoonabadi, Payam Sarraf, Sara Movahed, Akram Panahi, Bentolhoda Ziaadini, Mohammad Yazdchi, Jalal Bakhtiyari & Shahriar Nafissi. (2023) Iranian clinical practice guideline for amyotrophic lateral sclerosis. Frontiers in Neurology 14.
Crossref
Crossref
Riya Ben Patel, Akhilesh Kumar Bajpai & Kavitha Thirumurugan. (2023) Differential Expression of MicroRNAs and Predicted Drug Target in Amyotrophic Lateral Sclerosis. Journal of Molecular Neuroscience 73:6, pages 375-390.
Crossref
Crossref
Baoyi Huang, Xiang Geng, Zhiyin Yu, Chengfeng Zhang & Zheng Chen. (2023) Dynamic effects of prognostic factors and individual survival prediction for amyotrophic lateral sclerosis disease. Annals of Clinical and Translational Neurology 10:6, pages 892-903.
Crossref
Crossref
Cory J. Holdom, Jordi W. J. van Unnik, Ruben P. A. van Eijk, Leonard H. van den Berg, Robert D. Henderson, Shyuan T. Ngo & Frederik J. Steyn. (2023) Use of hip- versus wrist-based actigraphy for assessing functional decline and disease progression in patients with motor neuron disease. Journal of Neurology 270:5, pages 2597-2605.
Crossref
Crossref
Venkateswaran Rajagopalan, Krishna G. Chaitanya & Erik P. Pioro. (2023) Quantitative Brain MRI Metrics Distinguish Four Different ALS Phenotypes: A Machine Learning Based Study. Diagnostics 13:9, pages 1521.
Crossref
Crossref
Umberto Manera, Fabrizio D'Ovidio, Sara Cabras, Maria Claudia Torrieri, Antonio Canosa, Rosario Vasta, Francesca Palumbo, Maurizio Grassano, Fabiola De Marchi, Letizia Mazzini, Gabriele Mora, Cristina Moglia, Andrea Calvo & Adriano Chiò. (2023) Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions. European Journal of Neurology 30:4, pages 872-880.
Crossref
Crossref
Antonio Canosa, Alessio Martino, Alessandro Giuliani, Cristina Moglia, Rosario Vasta, Maurizio Grassano, Francesca Palumbo, Sara Cabras, Francesca Di Pede, Filippo De Mattei, Enrico Matteoni, Giulia Polverari, Umberto Manera, Andrea Calvo, Marco Pagani & Adriano Chiò. (2022) Brain metabolic differences between pure bulbar and pure spinal ALS: a 2-[18F]FDG-PET study. Journal of Neurology 270:2, pages 953-959.
Crossref
Crossref
Antonio Canosa, Alessio Martino, Umberto Manera, Rosario Vasta, Maurizio Grassano, Francesca Palumbo, Sara Cabras, Francesca Di Pede, Vincenzo Arena, Cristina Moglia, Alessandro Giuliani, Andrea Calvo, Adriano Chiò & Marco Pagani. (2022) Role of brain 2-[18F]fluoro-2-deoxy-D-glucose-positron-emission tomography as survival predictor in amyotrophic lateral sclerosis. European Journal of Nuclear Medicine and Molecular Imaging 50:3, pages 784-791.
Crossref
Crossref
Éilís Conroy, Polly Kennedy, Mark Heverin, Orla Hardiman & Miriam Galvin. (2023) Care, burden and self-described positive aspects of caring in amyotrophic lateral sclerosis: an exploratory, longitudinal, mixed-methods study. BMJ Open 13:1, pages e064254.
Crossref
Crossref
Meysam Ahangaran, Abdolrahman Peimankar, Uffe Kock Wiil & Adriano Chio. (2022) Impact of laboratory biomarkers on ALS disease progression: a probabilistic causation approach. Network Modeling Analysis in Health Informatics and Bioinformatics 11:1.
Crossref
Crossref
Harold H. G. Tan, Henk‐Jan Westeneng, Abram D. Nitert, Kevin van Veenhuijzen, Jil M. Meier, Hannelore K. van der Burgh, Martine J. E. van Zandvoort, Michael A. van Es, Jan H. Veldink & Leonard H. van den Berg. (2022)
MRI
Clustering Reveals Three
ALS
Subtypes With Unique Neurodegeneration Patterns
. Annals of Neurology 92:6, pages 1030-1045.
Crossref
Crossref
Arianna Polverino, Emahnuel Troisi Lopez, Roberta Minino, Marianna Liparoti, Antonella Romano, Francesca Trojsi, Fabio Lucidi, Leonardo Gollo, Viktor Jirsa, Giuseppe Sorrentino & Pierpaolo Sorrentino. (2022) Flexibility of Fast Brain Dynamics and Disease Severity in Amyotrophic Lateral Sclerosis. Neurology 99:21.
Crossref
Crossref
Mariana Dantas de Carvalho Vilar, Karla Monica Dantas Coutinho, Sancha Helena de Lima Vale, Gidyenne Christine Bandeira Silva Medeiros, Grasiela Piuvezam, Lucia Leite-Lais & Jose Brandao-Neto. (2022) Nutritional therapy in amyotrophic lateral sclerosis: protocol for a systematic review and meta-analysis. BMJ Open 12:8, pages e064086.
Crossref
Crossref
Antonio Canosa, Andrea Calvo, Cristina Moglia, Rosario Vasta, Francesca Palumbo, Luca Solero, Francesca Di Pede, Sara Cabras, Vincenzo Arena, Grazia Zocco, Federico Casale, Maura Brunetti, Luca Sbaiz, Salvatore Gallone, Maurizio Grassano, Umberto Manera, Marco Pagani & Adriano Chiò. (2022) Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes. European Journal of Nuclear Medicine and Molecular Imaging 49:7, pages 2242-2250.
Crossref
Crossref
Ana Cristina Calvo, Inés Valledor-Martín, Laura Moreno-Martínez, Janne Markus Toivonen & Rosario Osta. (2022) Lessons to Learn from the Gut Microbiota: A Focus on Amyotrophic Lateral Sclerosis. Genes 13:5, pages 865.
Crossref
Crossref
Ruben P A van Eijk, L H van den Berg & Ying Lu. (2022) Composite endpoint for ALS clinical trials based on patient preference: Patient-Ranked Order of Function (PROOF). Journal of Neurology, Neurosurgery & Psychiatry 93:5, pages 539-546.
Crossref
Crossref
Stefan Dukic, Roisin McMackin, Emmet Costello, Marjorie Metzger, Teresa Buxo, Antonio Fasano, Rangariroyashe Chipika, Marta Pinto-Grau, Christina Schuster, Michaela Hammond, Mark Heverin, Amina Coffey, Michael Broderick, Parameswaran M Iyer, Kieran Mohr, Brighid Gavin, Russell McLaughlin, Niall Pender, Peter Bede, Muthuraman Muthuraman, Leonard H van den Berg, Orla Hardiman & Bahman Nasseroleslami. (2022) Resting-state EEG reveals four subphenotypes of amyotrophic lateral sclerosis. Brain 145:2, pages 621-631.
Crossref
Crossref
Ina Schlichte, Susanne Petri, Reinhard Dengler, Thomas Meyer, Aiden Haghikia, Stefan Vielhaber & Susanne Vogt. (2022) Pain-Related Coping Behavior in ALS: The Interplay between Maladaptive Coping, the Patient’s Affective State and Pain. Journal of Clinical Medicine 11:4, pages 944.
Crossref
Crossref
Anna Behler, Hans-Peter Müller, Albert C. Ludolph, Dorothée Lulé & Jan Kassubek. (2022) A multivariate Bayesian classification algorithm for cerebral stage prediction by diffusion tensor imaging in amyotrophic lateral sclerosis. NeuroImage: Clinical 35, pages 103094.
Crossref
Crossref
Ernesto Iadanza, Rachele Fabbri, Francesco Goretti, Giovanni Nardo, Elena Niccolai, Caterina Bendotti & Amedeo Amedei. (2022) Machine learning for analysis of gene expression data in fast- and slow-progressing amyotrophic lateral sclerosis murine models. Biocybernetics and Biomedical Engineering 42:1, pages 273-284.
Crossref
Crossref
Jiahui Tang, Yuan Yang, Zhenxiang Gong, Zehui Li, Lifang Huang, Fengfei Ding, Mao Liu & Min Zhang. (2021) Plasma Uric Acid Helps Predict Cognitive Impairment in Patients With Amyotrophic Lateral Sclerosis. Frontiers in Neurology 12.
Crossref
Crossref
Alessandro Introna, Giammarco Milella, Antonella Morea, Maria Ucci, Angela Fraddosio, Stefano Zoccolella, Eustachio D'Errico & Isabella Laura Simone. (2021) King's college progression rate at first clinical evaluation: A new measure of disease progression in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 431, pages 120041.
Crossref
Crossref
Emma M. Devenney, Kate McErlean, Nga Yan Tse, Jashelle Caga, Thanuja Dharmadasa, William Huynh, Colin J. Mahoney, Margaret Zoing, Srestha Mazumder, Carol Dobson-Stone, John B. Kwok, Glenda M. Halliday, John R. Hodges, Olivier Piguet, Rebekah M. Ahmed & Matthew C. Kiernan. (2021) Factors That Influence Non-Motor Impairment Across the ALS-FTD Spectrum: Impact of Phenotype, Sex, Age, Onset and Disease Stage. Frontiers in Neurology 12.
Crossref
Crossref
Cory J. Holdom, Mark R. Janse van Mantgem, Ruben P. A. van Eijk, Stephanie L. Howe, Leonard H. van den Berg, Pamela A. McCombe, Robert D. Henderson, Shyuan T. Ngo & Frederik J. Steyn. (2021) Venous creatinine as a biomarker for loss of fat‐free mass and disease progression in patients with amyotrophic lateral sclerosis. European Journal of Neurology 28:11, pages 3615-3625.
Crossref
Crossref
Özden O. Dalgıç, Haoran Wu, F. Safa Erenay, Mustafa Y. Sir, Osman Y. Özaltın, Brian A. Crum & Kalyan S. Pasupathy. (2021) Mapping of critical events in disease progression through binary classification: Application to amyotrophic lateral sclerosis. Journal of Biomedical Informatics 123, pages 103895.
Crossref
Crossref
Susanne Vogt, Ina Schlichte, Stefanie Schreiber, Bernadette Wigand, Grazyna Debska-Vielhaber, Johanna Heitmann, Thomas Meyer, Reinhard Dengler, Susanne Petri, Aiden Haghikia & Stefan Vielhaber. (2021) A Multi-Center Cohort Study on Characteristics of Pain, Its Impact and Pharmacotherapeutic Management in Patients with ALS. Journal of Clinical Medicine 10:19, pages 4552.
Crossref
Crossref
Pavel Schischlevskij, Isabell Cordts, René Günther, Benjamin Stolte, Daniel Zeller, Carsten Schröter, Ute Weyen, Martin Regensburger, Joachim Wolf, Ilka Schneider, Andreas Hermann, Moritz Metelmann, Zacharias Kohl, Ralf A. Linker, Jan Christoph Koch, Claudia Stendel, Lars H. Müschen, Alma Osmanovic, Camilla Binz, Thomas Klopstock, Johannes Dorst, Albert C. Ludolph, Matthias Boentert, Tim Hagenacker, Marcus Deschauer, Paul Lingor, Susanne Petri & Olivia Schreiber-Katz. (2021) Informal Caregiving in Amyotrophic Lateral Sclerosis (ALS): A High Caregiver Burden and Drastic Consequences on Caregivers’ Lives. Brain Sciences 11:6, pages 748.
Crossref
Crossref
Antonio Canosa, Andrea Calvo, Cristina Moglia, Umberto Manera, Rosario Vasta, Francesca Di Pede, Sara Cabras, Davide Nardo, Vincenzo Arena, Maurizio Grassano, Fabrizio D’Ovidio, Koen Van Laere, Philip Van Damme, Marco Pagani & Adriano Chiò. (2020) Brain metabolic changes across King’s stages in amyotrophic lateral sclerosis: a 18F-2-fluoro-2-deoxy-d-glucose-positron emission tomography study. European Journal of Nuclear Medicine and Molecular Imaging 48:4, pages 1124-1133.
Crossref
Crossref
Tara Peseschkian, Isabell Cordts, René Günther, Benjamin Stolte, Daniel Zeller, Carsten Schröter, Ute Weyen, Martin Regensburger, Joachim Wolf, Ilka Schneider, Andreas Hermann, Moritz Metelmann, Zacharias Kohl, Ralf A. Linker, Jan Christoph Koch, Boriana Büchner, Ulrike Weiland, Erik Schönfelder, Felix Heinrich, Alma Osmanovic, Thomas Klopstock, Johannes Dorst, Albert C. Ludolph, Matthias Boentert, Tim Hagenacker, Marcus Deschauer, Paul Lingor, Susanne Petri & Olivia Schreiber-Katz. (2021) A Nation-Wide, Multi-Center Study on the Quality of Life of ALS Patients in Germany. Brain Sciences 11:3, pages 372.
Crossref
Crossref
Ammar Al-Chalabi, Adriano Chiò, Charlotte Merrill, Gerry Oster, Rebecca Bornheimer, Wendy Agnese & Stephen Apple. (2021) Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19. Journal of Neurology, Neurosurgery & Psychiatry 92:2, pages 165-171.
Crossref
Crossref
Barbara IazzolinoLaura PeottaJean Pierre ZucchettiAntonio CanosaUmberto ManeraRosario VastaMaurizio GrassanoFrancesca PalumboMaura BrunettiMarco BarberisLuca SbaizCristina MogliaAndrea CalvoAdriano Chiò. (2021)
Differential Neuropsychological Profile of Patients With Amyotrophic Lateral Sclerosis With and Without
C9orf72
Mutation
. Neurology 96:1.
Crossref
Crossref
Judith Machts, Marius Keute, Joern Kaufmann, Stefanie Schreiber, Elisabeth Kasper, Susanne Petri, Johannes Prudlo, Stefan Vielhaber & Mircea Ariel Schoenfeld. (2021) Longitudinal clinical and neuroanatomical correlates of memory impairment in motor neuron disease. NeuroImage: Clinical 29, pages 102545.
Crossref
Crossref
Kazuo Sugimoto, Yi Han, Yuebo Song & Ying Gao. (2020) Correlational Analysis of ALS Progression and Serum NfL Measured by Simoa Assay in Chinese Patients. Frontiers in Neurology 11.
Crossref
Crossref
Erik Schönfelder, Alma Osmanovic, Lars Hendrik Müschen, Susanne Petri & Olivia Schreiber-Katz. (2020) Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany. Orphanet Journal of Rare Diseases 15:1.
Crossref
Crossref
Nimish J. Thakore, Erik P. Pioro, Belinda L. Udeh, Brittany R. Lapin & Irene L. Katzan. (2020) A Cost-Effectiveness Framework for Amyotrophic Lateral Sclerosis, Applied to Riluzole. Value in Health 23:12, pages 1543-1551.
Crossref
Crossref
Monica Consonni, Eleonora Dalla Bella, Valeria Elisa Contarino, Enrica Bersano & Giuseppe Lauria. (2020) Cortical thinning trajectories across disease stages and cognitive impairment in amyotrophic lateral sclerosis. Cortex 131, pages 284-294.
Crossref
Crossref
Donatienne Van Weehaeghe, Martijn Devrome, Georg Schramm, Joke De Vocht, Wies Deckers, Kristof Baete, Philip Van Damme, Michel Koole & Koen Van Laere. (2020) Combined brain and spinal FDG PET allows differentiation between ALS and ALS mimics. European Journal of Nuclear Medicine and Molecular Imaging 47:11, pages 2681-2690.
Crossref
Crossref
Pramod Kumar Pisharady, Lynn E. Eberly, Ian Cheong, Georgios Manousakis, Gaurav Guliani, H. Brent Clark, Mark Bathe, David Walk & Christophe Lenglet. (2020) Tract-specific analysis improves sensitivity of spinal cord diffusion MRI to cross-sectional and longitudinal changes in amyotrophic lateral sclerosis. Communications Biology 3:1.
Crossref
Crossref
Thomas Meyer, Dagmar Kettemann, André Maier, Torsten Grehl, Ute Weyen, Julian Grosskreutz, Robert Steinbach, Jenny Norden, Annette George, Andreas Hermann, René Guenther, Susanne Petri, Olivia Schreiber-Katz, Johannes Dorst, Albert C Ludolph, Bertram Walter, Christoph Münch & Susanne Spittel. (2020) Symptomatic pharmacotherapy in ALS: data analysis from a platform-based medication management programme. Journal of Neurology, Neurosurgery & Psychiatry 91:7, pages 783-785.
Crossref
Crossref
Donatienne van Weehaeghe, Jenny Ceccarini, Stefanie M. Willekens, Joke de Vocht, Philip van Damme & Koen van Laere. (2020) Is there a glucose metabolic signature of spreading TDP-43 pathology in amyotrophic lateral sclerosis?. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 64:1.
Crossref
Crossref
Umberto Manera, Andrea Calvo, Margherita Daviddi, Antonio Canosa, Rosario Vasta, Maria Claudia Torrieri, Maurizio Grassano, Maura Brunetti, Sandra D'Alfonso, Lucia Corrado, Fabiola De Marchi, Cristina Moglia, Fabrizio D'Ovidio, Gabriele Mora, Letizia Mazzini & Adriano Chiò. (2020) Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: a population-based study. Journal of Neurology, Neurosurgery & Psychiatry 91:3, pages 291-297.
Crossref
Crossref
Robert Steinbach, Meerim Batyrbekova, Nayana Gaur, Annika Voss, Beatrice Stubendorff, Thomas E. Mayer, Christian Gaser, Otto W. Witte, Tino Prell & Julian Grosskreutz. (2020) Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis. NeuroImage: Clinical 25, pages 102094.
Crossref
Crossref
Ruben P. A. van Eijk, Jaap N. E. Bakers, Tommy M. Bunte, Arianne J. de Fockert, Marinus J. C. Eijkemans & Leonard H. van den Berg. (2019) Accelerometry for remote monitoring of physical activity in amyotrophic lateral sclerosis: a longitudinal cohort study. Journal of Neurology 266:10, pages 2387-2395.
Crossref
Crossref
Adriano ChiòCristina MogliaAntonio CanosaUmberto ManeraRosario VastaMaura BrunettiMarco BarberisLucia CorradoSandra D'AlfonsoEnrica BersanoMaria Francesca SarnelliValentina SolaraJean Pierre ZucchettiLaura PeottaBarbara IazzolinoLetizia MazziniGabriele MoraAndrea Calvo. (2019) Cognitive impairment across ALS clinical stages in a population-based cohort. Neurology 93:10.
Crossref
Crossref
P. Corcia, S. Beltran, G. Lautrette, S. Bakkouche & P. Couratier. (2019) Staging amyotrophic lateral sclerosis: A new focus on progression. Revue Neurologique 175:5, pages 277-282.
Crossref
Crossref
Alessandro Zandonà, Rosario Vasta, Adriano Chiò & Barbara Di Camillo. (2019) A Dynamic Bayesian Network model for the simulation of Amyotrophic Lateral Sclerosis progression. BMC Bioinformatics 20:S4.
Crossref
Crossref
Ian Cheong, Dinesh K Deelchand, Lynn E Eberly, Małgorzata Marjańska, Georgios Manousakis, Gaurav Guliani, David Walk & Gülin Öz. (2019) Neurochemical correlates of functional decline in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery & Psychiatry 90:3, pages 294-301.
Crossref
Crossref
Özden O. Dalgıç, F. Safa Erenay, Kalyan S. Pasupathy, Osman Y. Özaltın, Brian A. Crum & Mustafa Y. Sir. (2019) Tollgate-based progression pathways of ALS patients. Journal of Neurology 266:3, pages 755-765.
Crossref
Crossref
Vincent Grollemund, Pierre-François Pradat, Giorgia Querin, François Delbot, Gaétan Le Chat, Jean-François Pradat-Peyre & Peter Bede. (2019) Machine Learning in Amyotrophic Lateral Sclerosis: Achievements, Pitfalls, and Future Directions. Frontiers in Neuroscience 13.
Crossref
Crossref
Emily C. Bruggeman & Bing Yao. 2019. The DNA, RNA, and Histone Methylomes. The DNA, RNA, and Histone Methylomes
103
140
.
Peter Bede, Taha Omer, Eoin Finegan, Rangariroyashe H. Chipika, Parameswaran M. Iyer, Mark A. Doherty, Alice Vajda, Niall Pender, Russell L. McLaughlin, Siobhan Hutchinson & Orla Hardiman. (2018) Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: a multimodal neuroimaging study. Brain Imaging and Behavior 12:6, pages 1696-1707.
Crossref
Crossref
Yifang Bao, Liqin Yang, Yan Chen, Biyun Zhang, Haiqing Li, Weijun Tang, Daoying Geng & Yuxin Li. (2018) Radial diffusivity as an imaging biomarker for early diagnosis of non-demented amyotrophic lateral sclerosis. European Radiology 28:12, pages 4940-4948.
Crossref
Crossref
Cristina Viguera, Jiangxia Wang, Elizabeth Mosmiller, Aiana Cerezo & Nicholas J. Maragakis. (2018) Olfactory dysfunction in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology 5:8, pages 976-981.
Crossref
Crossref
Xueping Chen, Qian-Qian Wei, Yongping Chen, Bei Cao, RuWei Ou, Yanbing Hou, Xiaoqin Yuan, Lingyu Zhang, Hui Liu & Huifang Shang. (2018) Clinical Staging of Amyotrophic Lateral Sclerosis in Chinese Patients. Frontiers in Neurology 9.
Crossref
Crossref
Ton Fang, Ahmad Al Khleifat, Jacques-Henri Meurgey, Ashley Jones, P Nigel Leigh, Gilbert Bensimon & Ammar Al-Chalabi. (2018) Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study. The Lancet Neurology 17:5, pages 416-422.
Crossref
Crossref
Dorothée Lulé, Sarah Böhm, Hans-Peter Müller, Helena Aho-Özhan, Jürgen Keller, Martin Gorges, Markus Loose, Jochen H. Weishaupt, Ingo Uttner, Elmar Pinkhardt, Jan Kassubek, Kelly Del Tredici, Heiko Braak, Sharon Abrahams & Albert C. Ludolph. (2018) Cognitive phenotypes of sequential staging in amyotrophic lateral sclerosis. Cortex 101, pages 163-171.
Crossref
Crossref
Mary Kay Floeter, Laura E Danielian, Laura E Braun & Tianxia Wu. (2018)
Longitudinal diffusion imaging across the
C9orf72
clinical spectrum
. Journal of Neurology, Neurosurgery & Psychiatry 89:1, pages 53-60.
Crossref
Crossref
David Walk. 2018. Clinical Handbook of Neuromuscular Medicine. Clinical Handbook of Neuromuscular Medicine
57
74
.
Orla Hardiman, Ammar Al-Chalabi, Adriano Chio, Emma M. Corr, Giancarlo Logroscino, Wim Robberecht, Pamela J. Shaw, Zachary Simmons & Leonard H. van den Berg. (2017) Amyotrophic lateral sclerosis. Nature Reviews Disease Primers 3:1.
Crossref
Crossref
Tom Burke, Marta Pinto-Grau, Katie Lonergan, Peter Bede, Meabhdh O'Sullivan, Mark Heverin, Alice Vajda, Russell L. McLaughlin, Niall Pender & Orla Hardiman. (2017) A Cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: subphenotypes, staging, cognitive predictors, and survival. Annals of Clinical and Translational Neurology 4:5, pages 305-317.
Crossref
Crossref
Sarah Martin, Ahmad Al Khleifat & Ammar Al-Chalabi. (2017) What causes amyotrophic lateral sclerosis?. F1000Research 6, pages 371.
Crossref
Crossref
Ton Fang, Felix Jozsa & Ammar Al-Chalabi. 2017. Nonmotor Parkinson’s: The Hidden Face - Management and the Hidden Face of Related Disorders. Nonmotor Parkinson’s: The Hidden Face - Management and the Hidden Face of Related Disorders
1409
1441
.
D. Ferraro, D. Consonni, N. Fini, A. Fasano, C. Del Giovane & J. Mandrioli. (2016) Amyotrophic lateral sclerosis: a comparison of two staging systems in a population‐based study. European Journal of Neurology 23:9, pages 1426-1432.
Crossref
Crossref
Rubika Balendra & Rickie Patani. (2016) Quo vadis motor neuron disease?. World Journal of Methodology 6:1, pages 56.
Crossref
Crossref
Kexin AngThirugnanam Umapathi, Jieli Tong, Justin Ng, Liang Jun Tseng & Ivan Mun Hong Woo. (2017) Healthcare Needs of Patients with Amyotrophic Lateral Sclerosis (ALS) in Singapore: A patient-centred qualitative study from multiple perspectives. Journal of Palliative Care 31:3, pages 150-157.
Crossref
Crossref
Ana C. Calvo, Raquel Manzano, Deise M. F. Mendonça, María J. Muñoz, Pilar Zaragoza & Rosario Osta. (2014) Amyotrophic Lateral Sclerosis: A Focus on Disease Progression. BioMed Research International 2014, pages 1-12.
Crossref
Crossref